Thrombotic and infectious complications of central venous catheters in patients with hematological malignancies

Annals of Oncology

Volumn 19, Issue 3, 2008, Pages 433-442

  Boersma, Rinske S ^a   Jie, K S G ^a   Verbon, A ^b   van Pampus, E C M ^b   Schouten, H C ^b  

^a Sittard Geleen Heerlen   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Central venous catheter related infections; Central venous catheter related thrombosis; Hematological malignancies

Indexed keywords

ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTIFUNGAL AGENT; CHLORHEXIDINE; CIPROFLOXACIN; DALTEPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; MINOCYCLINE; NADROPARIN; RIFAMPICIN; SULFADIAZINE SILVER; TEICOPLANIN; UROKINASE; VANCOMYCIN; WARFARIN;

ANTIMICROBIAL THERAPY; BIOCOMPATIBILITY; BLOOD VESSEL RUPTURE; CATHETER CARE; CATHETER COMPLICATION; CATHETER INFECTION; CATHETER REMOVAL; CATHETER THROMBOSIS; CENTRAL VENOUS CATHETER; CLINICAL TRIAL; CONTINUOUS INFUSION; DIAGNOSTIC ACCURACY; DISEASE COURSE; DOPPLER FLOWMETRY; DRUG CONTRAINDICATION; FIBRINOLYTIC THERAPY; HEMATOLOGIC MALIGNANCY; HUMAN; LOW DRUG DOSE; LUNG EMBOLISM; NEUTROPENIA; PHLEBOGRAPHY; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

EID: 40149085869     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdm350     Document Type: Review

References (85)

1. D.C. McGee M.K. Gould Preventing complications of central venous catheterization N Engl J Med 348 2003 1123 1133
2. W.R. Jarvis Selected aspects of the socioeconomic impact of nosocomial infections: morbidity, mortality, cost, and prevention Infect Control Hosp Epidemiol 17 1996 552 557
3. D. Pittet D. Tarara R.P. Wenzel Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality JAMA 271 1994 1598 1601
4. A. Cortelezzi M. Moia A. Falanga Incidence of thrombotic complications in patients with haematological malignancies with central venous catheters: a prospective multicentre study Br J Haematol 129 2005 811 817
5. K.V. Rolston Prediction of neutropenia Int J Antimicrob Agents 16 2000 113 115
6. C.J. van Rooden F.R. Rosendaal R.M. Barge Central venous catheter related thrombosis in haematology patients and prediction of risk by screening with Doppler-ultrasound Br J Haematol 123 2003 507 512
7. T. Pottecher M. Forrler P. Picardat Thrombogenicity of central venous catheters: prospective study of polyethylene, silicone and polyurethane catheters with phlebography or post-mortem examination Eur J Anaesthesiol 1 1984 361 365
8. A. Abdelkefi L. Torjman S. Ladeb Randomized trial of prevention of catheter-related bloodstream infection by continuous infusion of low-dose unfractionated heparin in patients with hematologic and oncologic disease J Clin Oncol 23 2005 7864 7870
9. S.W. Lagro L.F. Verdonck I.H. Borel Rinkes A.W. Dekker No effect of nadroparin prophylaxis in the prevention of central venous catheter (CVC)-associated thrombosis in bone marrow transplant recipients Bone Marrow Transplant 26 2000 1103 1106
10. P. Boraks J. Seale J. Price Prevention of central venous catheter associated thrombosis using minidose warfarin in patients with haematological malignancies Br J Haematol 101 1998 483 486
11. M. Monreal E. Lafoz J. Ruiz Upper-extremity deep venous thrombosis and pulmonary embolism. A prospective study Chest 99 1991 280 283
12. M. Monreal A. Raventos R. Lerma Pulmonary embolism in patients with upper extremity DVT associated to venous central lines—a prospective study Thromb Haemost 72 1994 548 550
13. P. Prandoni P. Polistena E. Bernardi Upper-extremity deep vein thrombosis. Risk factors, diagnosis, and complications Arch Intern Med 157 1997 57 62
14. F. Lordick M. Hentrich T. Decker Ultrasound screening for internal jugular vein thrombosis aids the detection of central venous catheter-related infections in patients with haemato-oncological diseases: a prospective observational study Br J Haematol 120 2003 1073 1078
15. J.M. Journeycake G.R. Buchanan Catheter-related deep venous thrombosis and other catheter complications in children with cancer J Clin Oncol 24 2006 4575 4580
16. M. RaadLuna II S.A. Khalil The relationship between the thrombotic and infectious complications of central venous catheters JAMA 271 1994 1014 1016
17. A.Y. Lee M.N. Levine G. Butler Incidence, risk factors, and outcomes of catheter-related thrombosis in adult patients with cancer J Clin Oncol 24 2006 1404 1408
18. M.M. Bern J.J. Lokich S.R. Wallach Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial Ann Intern Med 112 1990 423 428
19. A. Cortelezzia N.S. Fracchiolla P. Maisonneuve Central venous catheter-related complications in patients with hematological malignancies: a retrospective analysis of risk factors and prophylactic measures Leuk Lymphoma 44 2003 1495 1501
20. C. Martin X. Viviand P. Saux F. Gouin Upper-extremity deep vein thrombosis after central venous catheterization via the axillary vein Crit Care Med 27 1999 2626 2629
21. D.Z. Xiang E.K. Verbeken A.T. Van Lommel Composition and formation of the sleeve enveloping a central venous catheter J Vasc Surg 28 1998 260 271
22. B.J. Eastridge A.T. Lefor Complications of indwelling venous access devices in cancer patients J Clin Oncol 13 1995 233 238
23. A. Luciani O. Clement P. Halimi Catheter-related upper extremity deep venous thrombosis in cancer patients: a prospective study based on Doppler US Radiology 220 2001 655 660
24. M.E. Tesselaar J. Ouwerkerk M.A. Nooy Risk factors for catheter-related thrombosis in cancer patients Eur J Cancer 40 2004 2253 2259
25. C. Male P. Chait M. Andrew Central venous line-related thrombosis in children: association with central venous line location and insertion technique Blood 101 2003 4273 4278
26. R. Fijnheer B. Paijmans L.F. Verdonck Factor V Leiden in central venous catheter-associated thrombosis Br J Haematol 118 2002 267 270
27. C.J. Van Rooden F.R. Rosendaal A.E. Meinders The contribution of factor V Leiden and prothrombin G20210A mutation to the risk of central venous catheter-related thrombosis Haematologica 89 2004 201 206
28. M. Ratcliffe C. Broadfoot M. Davidson Thrombosis, markers of thrombotic risk, indwelling central venous catheters and antithrombotic prophylaxis using low-dose warfarin in subjects with malignant disease Clin Lab Haematol 21 1999 353 357
29. C.J. van Rooden E.F. Schippers R.M. Barge Infectious complications of central venous catheters increase the risk of catheter-related thrombosis in hematology patients: a prospective study J Clin Oncol 23 2005 2655 2660
30. J.F. Timsit J.C. Farkas J.M. Boyer Central vein catheter-related thrombosis in intensive care patients: incidence, risks factors, and relationship with catheter-related sepsis Chest 114 1998 207 213
31. B.O. Mustafa S.W. Rathbun T.L. Whitsett G.E. Raskob Sensitivity and specificity of ultrasonography in the diagnosis of upper extremity deep vein thrombosis: a systematic review Arch Intern Med 162 2002 401 404
32. C.J. Van Rooden P.S. Monraats I.M. Kettenis Low physician compliance of prescribing anticoagulant prophylaxis in patients with solid tumor or hematological malignancies and central vein catheters J Thromb Haemost 1 2003 1842 1843
33. K.M. Carr I. Rabinowitz Physician compliance with warfarin prophylaxis for central venous catheters in patients with solid tumors J Clin Oncol 18 2000 3665 3667
34. S. Couban M. Goodyear M. Burnell Randomized placebo-controlled study of low-dose warfarin for the prevention of central venous catheter-associated thrombosis in patients with cancer J Clin Oncol 23 2005 4063 4069
35. A. Abdelkefi T. Ben Othman L. Kammoun Prevention of central venous line-related thrombosis by continuous infusion of low-dose unfractionated heparin, in patients with haemato-oncological disease. A randomized controlled trial Thromb Haemost 92 2004 654 661
36. P.W. Dillon G.R. Jones H.A. Bagnall-Reeb Prophylactic urokinase in the management of long-term venous access devices in children: a Children's Oncology Group study J Clin Oncol 22 2004 2718 2723
37. M. Magagnoli G. Masci L. Castagna Prophylaxis of central venous catheter-related thrombosis with minidose warfarin in patients treated with high-dose chemotherapy and peripheral-blood stem-cell transplantation: retrospective analysis of 228 cancer patients Am J Hematol 81 2006 1 4
38. H.R. Buller G. Agnelli R.D. Hull Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest 126 2004 401S 428S
39. O. Karabay U. Yetkin H. Onol Upper extremity deep vein thrombosis: clinical and treatment characteristics J Int Med Res 32 2004 429 435
40. D.A. Frank J. Meuse D. Hirsch The treatment and outcome of cancer patients with thromboses on central venous catheters J Thromb Thrombolysis 10 2000 271 275
41. MJ Kovacs SR Kahn M Rodger. A pilot study of central venous catheter survival in cancer patients using low molecular weight heparin (dalteparin) and warfarin without catheter removal for the treatment of upper extremity deep vein thrombosis (the catheter study)J Thromb Haemost 2007; May 7 [Epub ahead of print]
42. P.E. Drakos A. Nagler R. Or Low molecular weight heparin for Hickman catheter–induced thrombosis in thrombocytopenic patients undergoing bone marrow transplantation Cancer 70 1992 1895 1898
43. S. Sabeti M. Schillinger W. Mlekusch Treatment of subclavian-axillary vein thrombosis: long-term outcome of anticoagulation versus systemic thrombolysis Thromb Res 108 2002 279 285
44. D. Ponec D. Irwin W.D. Haire Recombinant tissue plasminogen activator (alteplase) for restoration of flow in occluded central venous access devices: a double-blind placebo-controlled trial—the Cardiovascular Thrombolytic to Open Occluded Lines (COOL) efficacy trial J Vasc Interv Radiol 12 2001 951 955
45. C.A. Monturo R.N. Dickerson J.L. Mullen Efficacy of thrombolytic therapy for occlusion of long-term catheters JPEN J Parenter Enteral Nutr 14 1990 312 314
46. L.A. Mermel B.M. Farr R.J. Sherertz Guidelines for the management of intravascular catheter-related infections Clin Infect Dis 32 2001 1249 1272
47. N.P. O'Grady M. Alexander E.P. Dellinger Guidelines for the prevention of intravascular catheter-related infections Infect Control Hosp Epidemiol 23 2002 759 769
48. J.L. Nouwen J.J. Wielenga H. van Overhagen Hickman catheter-related infections in neutropenic patients: insertion in the operating theater versus insertion in the radiology suite J Clin Oncol 17 1999 1304
49. I.I. Raad H.A. Hanna Intravascular catheter-related infections: new horizons and recent advances Arch Intern Med 162 2002 871 878
50. B.W. Trautner R.O. Darouiche Catheter-associated infections: pathogenesis affects prevention Arch Intern Med 164 2004 842 850
51. N. Safdar D.G. Maki Inflammation at the insertion site is not predictive of catheter-related bloodstream infection with short-term, noncuffed central venous catheters Crit Care Med 30 2002 2632 2635
52. R. Freeman B. King Recognition of infection associated with intravenous catheters Br J Surg 62 1975 404 406
53. C. Brun-Buisson F. Abrouk P. Legrand Diagnosis of central venous catheter-related sepsis. Critical level of quantitative tip cultures Arch Intern Med 147 1987 873 877
54. D.J. Cleri M.L. Corrado S.J. Seligman Quantitative culture of intravenous catheters and other intravascular inserts J Infect Dis 141 1980 781 786
55. R.J. Sherertz I.I. Raad A. Belani Three-year experience with sonicated vascular catheter cultures in a clinical microbiology laboratory J Clin Microbiol 28 1990 76 82
56. D.G. Maki C.E. Weise H.W. Sarafin A semiquantitative culture method for identifying intravenous-catheter-related infection N Engl J Med 296 1977 1305 1309
57. J.A. Catton B.M. Dobbins P. Kite In situ diagnosis of intravascular catheter-related bloodstream infection: a comparison of quantitative culture, differential time to positivity, and endoluminal brushing Crit Care Med 33 2005 787 791
58. N. Safdar J.P. Fine D.G. Maki Meta-analysis: methods for diagnosing intravascular device-related bloodstream infection Ann Intern Med 142 2005 451 466
59. A. Abdelkefi W. Achour T. Ben Othman Difference in time to positivity is useful for the diagnosis of catheter-related bloodstream infection in hematopoietic stem cell transplant recipients Bone Marrow Transplant 35 2005 397 401
60. R.J. Sherertz S.O. Heard I.I. Raad Diagnosis of triple-lumen catheter infection: comparison of roll plate, sonication, and flushing methodologies J Clin Microbiol 35 1997 641 646
61. B.M. Dobbins P. Kite J.A. Catton In situ endoluminal brushing: a safe technique for the diagnosis of catheter-related bloodstream infection J Hosp Infect 58 2004 233 237
62. I.I. Raad D.C. Hohn B.J. Gilbreath Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion Infect Control Hosp Epidemiol 15 1994 231 238
63. P. Eggimann S. Hugonnet H. Sax Long-term reduction of vascular access-associated bloodstream infection Ann Intern Med 142 2005 875 876
64. T. Moller N. Borregaard M. Tvede L. Adamsen Patient education—a strategy for prevention of infections caused by permanent central venous catheters in patients with haematological malignancies: a randomized clinical trial J Hosp Infect 61 2005 330 341
65. K.J. Henrickson R.A. Axtell S.M. Hoover Prevention of central venous catheter-related infections and thrombotic events in immunocompromised children by the use of vancomycin/ciprofloxacin/heparin flush solution: A randomized, multicenter, double-blind trial J Clin Oncol 18 2000 1269 1278
66. Recommendations for preventing the spread of vancomycin resistance. Recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC) MMWR Recomm Rep 44 1995 1 13
67. P. Ljungman H. Hagglund B. Bjorkstrand Peroperative teicoplanin for prevention of Gram-positive infections in neutropenic patients with indwelling central venous catheters: a randomized, controlled study Support Care Cancer 5 1997 485 488
68. S.H. Lim M.P. Smith S.J. Machin A.H. Goldstone A prospective randomized study of prophylactic teicoplanin to prevent early Hickman catheter-related sepsis in patients receiving intensive chemotherapy for haematological malignancies Eur J Haematol 54 Suppl 1993 10 13
69. D.L. Veenstra S. Saint S. Saha Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis JAMA 281 1999 261 267
70. K. Jaeger S. Zenz B. Juttner Reduction of catheter-related infections in neutropenic patients: a prospective controlled randomized trial using a chlorhexidine and silver sulfadiazine-impregnated central venous catheter Ann Hematol 84 2005 258 262
71. C. Logghe C. Van Ossel W. D'Hoore Evaluation of chlorhexidine and silver-sulfadiazine impregnated central venous catheters for the prevention of bloodstream infection in leukaemic patients: a randomized controlled trial J Hosp Infect 37 1997 145 156
72. C.J. Crnich D.G. Maki Are antimicrobial-impregnated catheters effective? When does repetition reach the point of exhaustion? Clin Infect Dis 41 2005 681 685
73. C.J. Crnich D.G. Maki Are antimicrobial-impregnated catheters effective? Don't throw out the baby with the bathwater Clin Infect Dis 38 2004 1287 1292
74. S.A. McConnell P.O. Gubbins E.J. Anaissie Do antimicrobial-impregnated central venous catheters prevent catheter-related bloodstream infection? Clin Infect Dis 37 2003 65 72
75. M.E. Falagas K. Fragoulis I.A. Bliziotis I. Chatzinikolaou Rifampicin-impregnated central venous catheters: a meta-analysis of randomized controlled trials J Antimicrob Chemother 59 2007 359 369
76. H. Hanna R. Benjamin I. Chatzinikolaou Long-term silicone central venous catheters impregnated with minocycline and rifampin decrease rates of catheter-related bloodstream infection in cancer patients: a prospective randomized clinical trial J Clin Oncol 22 2004 3163 3171
77. I. Raad S. Davis A. Khan Impact of central venous catheter removal on the recurrence of catheter-related coagulase-negative staphylococcal bacteremia Infect Control Hosp Epidemiol 13 1992 215 221
78. P.A. Pizzo K.J. Robichaud F.A. Gill F.G. Witebsky Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia Am J Med 72 1982 101 111
79. P.G. Pappas J.H. Rex J.D. Sobel Guidelines for treatment of candidiasis Clin Infect Dis 38 2004 161 189
80. J.R. Mehall D.A. Saltzman R.J. Jackson S.D. Smith Fibrin sheath enhances central venous catheter infection Crit Care Med 30 2002 908 912
81. M. Herrmann P.E. Vaudaux D. Pittet Fibronectin, fibrinogen, and laminin act as mediators of adherence of clinical staphylococcal isolates to foreign material J Infect Dis 158 1988 693 701
82. G. Choi M.J. Schultz M. Levi T. van der Poll The relationship between inflammation and the coagulation system Swiss Med Wkly 136 2006 139 144
83. C.T. Esmon The interactions between inflammation and coagulation Br J Haematol 131 2005 417 430
84. M. Levi T. van der Poll H.R. Buller Bidirectional relation between inflammation and coagulation Circulation 109 2004 2698 2704
85. M.C. Weijmer M.A. van den Dorpel Van de Ven PJ et al. Randomized, clinical trial comparison of trisodium citrate 30% and heparin as catheter-locking solution in hemodialysis patients J Am Soc Nephrol 16 2005 2769 2777